News

News
Partner news

Philogen announces new collaboration with Janssen to discover small molecule therapeutics

Read full story
Partner news

Ultromics Announces Collaboration with Janssen to Develop AI for Patients with Amyloidosis with Cardiac Involvement

Read full story
Partner news

F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics

Read full story
Partner news

Whole Genome Sequencing data on 200,000 UK Biobank participants are made widely available for research

Read full story
Other news

Nature Communications Article, Co-Authored by Paul Stoffels and William N. Hait Explores Importance of Academic-industrial Partnerships in Life Science Innovation

Read full story
Partner news

Persephone Biosciences Inc. Announces Collaboration with Janssen Biotech, Inc.

Read full story
Other news

Ribon Therapeutics Secures $65 Million Financing

Read full story
Other news

Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)

Read full story
Other news

POINT Biopharma Debuts as Publicly Traded Next-Generation Radiotherapeutics Company

Read full story
Other news

TRexBio Closes the Final Tranche of $59 Million Series A Financing to Advance Innovation in Tissue Immunobiology for the treatment of Cancer and Inflammatory Diseases

Read full story
Other news

Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development

Read full story
Partner news

Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development

Read full story
Other news

Datavant and Ciox Health Announce Merger, Creating the Largest Neutral and Secure Health Data Ecosystem

Read full story
Other news

entrinsic bioscience Secures $49 million in Financing to Accelerate Development and Commercialization of Next Generation Functional Ingredients and Active Pharmaceutical Ingredients

Read full story
Other news

Thirty Madison Raises $140 Million in Series C Financing Led by HealthQuest Capital

Read full story